David J. Moss - 05 Dec 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Financial Officer, 10%+ Owner
Signature
/s/ David Moss
Issuer symbol
INMB
Transactions as of
05 Dec 2024
Transactions value $
$0
Form type
4
Filing time
09 Dec 2024, 16:00:30 UTC
Previous filing
30 Sep 2024
Next filing
18 Nov 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Option (right to buy) Award $0 +223K $0.00 223K 05 Dec 2024 Common Stock 223K $5.05 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the 2021 Stock Incentive Plan. The option will become 100% vested and exercisable on December 5, 2026, the two-year anniversary of the grant date.